WHO’s Obesity Guidelines: Benefits, Risks, and Long-Term Use of GLP-1 Drugs

The World Health Organization now recognizes obesity as a chronic disease and recommends GLP-1 weight loss drugs such as Ozempic and Mounjaro as part of long-term treatment. Until now, the…

“Overcoming Obesity: Redefining Health and Wellness”

Obesity is defined by the World Health Organisation (WHO) as an abnormal or excessive accumulation of fat that presents a risk to health. It is one of the most significant…